Skip to main content
. Author manuscript; available in PMC: 2013 Feb 15.
Published in final edited form as: Clin Cancer Res. 2012 Jan 6;18(4):1039–1050. doi: 10.1158/1078-0432.CCR-11-1429

Figure 6. CD20 overexpression in RRCL indicated a potential defect in CD20 transport to cell surface.

Figure 6

20×106 Raji2R, Hela or Jurkat (data not shown) Tcells were transfected with 4μg of CD20-BCMGSneo vector by Amaxa Nucleofection. On day 2 or 4, cells were harvested for CD20 expression analysis by (A) Western blot. CD20 and β-actin control expression on Western blot were quantified by Image Jsoftware. (B) 51Crrelease assay was performed for rituximab-associated CMC. (C) Flow cytometry for percentage of cells with CD20 overexpression in mock-transfected and CD20-BCMGSneo vector-transfected Raji2R cells. Raji cells were used as positive control. Transfection efficiency was demonstrated post pmaxGFP transfection by GFP-expressing population.